rheumatology
Medicines

Hydroxychloroquine trial controversy continues

Editors note: This story has been updated on 4/6/2020 to reflect study retractions: The World Health Organization has now resumed the SOLIDARITY trial of hydroxychloroquine after previously suspending it over safety concerns raised in a now retracted Lancet paper. WHO had earlier suspended the hydroxychloroquine arm of the SOLIDARITY trial in patients with COVID-19 after ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic